ArticleBMC infectious diseases2025
Seroprevalence and molecular detection of SARS-CoV-2 among apparently healthy healthcare workers and patients in a Nigerian tertiary hospital.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSARS-CoV-2 continues to drive community and healthcare-associated transmission globally, with limited data from sub-Saharan Africa on asymptomatic carriage and infection dynamics. We conducted a dual serological and molecular study to determine the prevalence of past and current SARS-CoV-2 infections among apparently healthy healthcare workers (HCWs) and patients in a Nigerian tertiary hospital.
methodsWe performed a cross-sectional study at the Federal Teaching Hospital, Gombe, Nigeria, enrolling 250 participants (35 HCWs and 215 patients). Venous blood samples were tested for anti-SARS-CoV-2 IgM/IgG antibodies using validated rapid diagnostic tests, while nasopharyngeal/oropharyngeal swabs were analysed by real-time reverse transcription polymerase chain reaction (qRT-PCR) targeting SARS-CoV-2 genes. Socio-demographic and behavioural data were collected via structured questionnaires. Data were analysed using descriptive statistics and chi-square tests, with significance set at p < 0.05.
resultsOverall, 42.0% (n = 105) of participants were seropositive for SARS-CoV-2 antibodies, predominantly IgG (41.6%), with minimal IgM detection (0.4%). Antibody prevalence was significantly higher among patients (37.6%) than HCWs (4.0%) (p < 0.001). SARS-CoV-2 RNA was detected in 42.8% (n = 107) of participants, all of whom were patients. No HCWs tested positive for active infection. All qRT-PCR–positive cases were also IgG positive, suggesting late-phase or resolving infections. Risk factor analysis revealed no statistically significant associations between infection and comorbidities such as hypertension, diabetes, or asthma (p > 0.05).
conclusionsThis study demonstrates substantial community transmission of SARS-CoV-2 among apparently healthy patients in a Nigerian tertiary hospital, contrasted with the absence of active infection among HCWs, which may reflect effective IPC practices, although other unmeasured factors could also contribute. The combined use of serology and molecular testing provided complementary insights into both past exposure and ongoing infections. Our findings highlight the importance of dual diagnostic strategies for surveillance in high-risk healthcare settings and reinforce the need for sustained IPC measures, alongside strengthened community-level interventions, to mitigate COVID-19 transmission in Nigeria. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.